PATENT CLAIM ANALYSIS

Application Number: 15971863
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["435", "320100"]

Abstract:
The present disclosure provides engineered polynucleotide sequences that form scaffolds and nucleoprotein complexes comprising such engineered polynucleotide sequences that form scaffolds and nucleic acid binding proteins. Nucleic acid sequences encoding the engineered polynucleotide sequences that form scaffolds, as well as expression cassettes, vectors and cells comprising such polynucleotide sequences, are described. A variety of methods for making and using the engineered polynucleotide sequences that form scaffolds are also disclosed.

Claim (Index 33):
The nucleic acid/protein composition of  claim 21 , wherein the first catalytically inactive Class 2 Type II CRISPR-Cas9 protein is different from the second catalytically inactive Class 2 Type II CRISPR-Cas9 protein, and the first catalytically inactive Class 2 Type II CRISPR-Cas9 protein and the second catalytically inactive Class 2 Type II CRISPR-Cas9 protein are each selected from the group consisting of a  Streptococcus pyogenes  Cas9 protein, a  Streptococcus thermophilus  Cas9 protein, a  Staphylococcus aureus  Cas9 protein, and a  Campylobacter jejuni  Cas9 protein.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 93.0
- Lexical Diversity: 1.82927
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15368570', '15703992', '15460642', '15331676', '15675677']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7848358379001078
- 35 USC 102 Novelty (BERT): 0.6682515555301523
- Combined Prediction Score: 0.7731774096631123
- Mean Citation Score: 661.3639
- Max Citation Score: 802.66437
- Similarity Product: 639.5825993828487

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test